Orlando Clinical Research Center
5055 South Orange Ave Orlando FL 32909
Orlando, Florida 32806
407-240-7878 http://www.ocrc.net tmarbury@ocrc.net

Use our guide to learn which trials are right for you!

Scope of Services

Phase I

  • First Time in Man Safety/Tolerance
  • Bioavailability/Bioequivalence
  • Pharmacokinetics/Pharmacodynamics
  • Dose-Response
  • Drug Interactions
  • Metabolic Balance

Phase II-IV

  • Clinical Efficacy and Safety
  • Dose Ranging and Definition
  • Special Populations
  • Claims and Labeling Support
  • Post Marketing Studies
  • Rx to OTC Conversion

OCRC has expertise in evaluating products and conducting research trials in the following areas of study:

  • Asthma
  • Anti-Infective (outpatient)
  • Analgesics
  • Bioavailability
  • CNS
  • Dermatology
  • Diabetes
  • Gastroenterology
  • Geriatrics
  • Hyperlipidemia
  • Hypertension
  • Nephrology
  • Nutrition
  • Pharmacokinetics
  • Psychiatry
  • Urinary Tract Infections
  • Weight Loss
  • Hormone Replacement Therapy
  • Smoking Cessation

Our streamlined and thorough planning, coordination and monitoring process ensures both efficiency and exacting quality. At OCRC we...

  • Enjoyed a close working relationship with IRBs so your research protocol can be reviewed and implemented in a timely manner.
  • Appoint a coordinator who is familiar with every aspect of your protocol to be a one-call source of information for you.
  • Support you in developing protocols by defining clinical parameters.
  • Implement a recruiting and scheduling deadline that will meet your milestone needs.
  • Provide outstanding patient care under the personal supervision of Dr. Marbury.
  • Adhere strictly to all GCP and GLP guidelines.
  • Update your project daily and inform you quickly and accurately about any adverse events.

Orlando is one of the fast-growing cities in the U.S. and the million-plus metro-area population encompasses all major demographic groups for patient populations.

OCRC has a broad participant base that is continually augmented and replenished by a highly successful recruiting program that taps private practices and local hospitals, universities and retirement communities.

  • Healthy volunteers
  • Hypertension
  • Diabetes
  • Renal Insufficiency
  • Elderly
  • Post-menopausal
  • Hepatic Dysfunction
  • Symptomatic Volunteers

Cardiology/Vascular Diseases
Dermatology/Plastic Surgery
Endocrinology
Gastroenterology
Nephrology/Urology
Neurology
Pharmacology/Toxicology
Psychiatry/Psychology
Rheumatology

Orlando Clinical Research Center (OCRC) is an independent Phase I-IV custom built 35,000 SF research site specifically designed for Phase 1 trials. The new facility includes 100 in-house volunteer beds, dual lead digital telemetry, an upgraded security system with card key access and digitally recorded cameras, as well as a special treatment area with 12 hospital beds (6 of which are plumbed for onsite hemodialysis).

  • 100 beds for subject confinement
  • Separate accommodations for men and women
  • Recreational amenities:
    • Pool table
    • computer room with high speed and modem internet connections
    • Direct TV
    • Cable TV in all rooms
    • VCR and DVD Players
  • 24 hour medical coverage
  • Private Client Monitoring Room
  • 12 exam rooms
  • Large special Treatment Lab with 12 hospital bed (6 are plumbed for dialysis)
  • Certified sample processing laboratory
  • Freezers: 2 (-70&degC) and 2 (-20&degC)
  • Refrigerated Centrifuge
  • Computerized EKG machines
  • Registered Dietitian Consultant

Thomas Marbury, M.D.
President
Orlando Clinical Research Center
5055 South Orange Ave
Orlando, FL 32909
USA
407-240-7878
407-240-9846 (fax)
tmarbury@ocrc.net
www.ocrc.net


We've found
15 trials
at this facility
Hepatic Impairment Clinical Trial
A Safety Study of Tucatinib in Healthy and Hepatically-Impaired Subjects
Status: Enrolling, Phase I
Updated: 12/31/1969
mi
from
Orlando, FL
Click here to add this to my saved trials
Hepatic Impairment Clinical Trial
A Hepatic Impairment Study for PF-04965842
Status: Enrolling, Phase I
Updated: 12/31/1969
mi
from
Orlando, FL
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Nephrology / Urology Clinical Trial
Safety and Efficacy Study of AB023 (Xisomab 3G3) in End Stage Renal Disease Patients on Chronic Hemodialysis
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Orlando, FL
Click here to add this to my saved trials
Gastroenterology Clinical Trial
Effect of Hepatic Impairment on LDK378 Pharmacokinetics
Status: Enrolling, Phase I
Updated: 3/3/2016
mi
from
Orlando, FL
Click here to add this to my saved trials
Hepatic Impairment Clinical Trial
MEK162 in Healthy Subjects With Normal Hepatic Function and Subjects With Impaired Hepatic Function
Status: Enrolling, Phase I
Updated: 1/30/2017
mi
from
Orlando, FL
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Nephrology / Urology Clinical Trial
A Study to Evaluate the Safety and Pharmacokinetics of BMS-986177 in Participants With End-stage Renal Dysfunction on Chronic Stable Hemodialysis Treatment
Status: Enrolling, Phase I
Updated: 12/22/2016
mi
from
Orlando, FL
Click here to add this to my saved trials
Nephrology / Urology Clinical Trial
A Study of Tirzepatide (LY3298176) in Participants With Impaired Kidney Function
Status: Enrolling, Phase I
Updated: 12/31/1969
mi
from
Orlando, FL
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
An Investigational Study to Evaluate Experimental Medication BMS-986224 in Renally Impaired Participants
Status: Enrolling, Phase I
Updated: 12/31/1969
mi
from
Orlando, FL
Click here to add this to my saved trials
Acute Kidney Injury Clinical Trial
Pharmacokinetics of MB-102 and Use of the Non-invasive Optical Renal Function Monitor (ORFM) Device in Subjects With Normal and Impaired Renal Function and a Range of Skin Color Types
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Orlando, FL
Click here to add this to my saved trials
Hepatic Impairment Clinical Trial
A Hepatic Impairment Study for PF-04965842.
Status: Enrolling, Phase I
Updated: 12/31/1969
mi
from
Orlando, FL
Click here to add this to my saved trials
Kidney Failure, Chronic Clinical Trial
A Study to Evaluate JNJ-64565111 Pharmacokinetics and Safety in Adult Participants With Varying Degrees of Renal Function
Status: Enrolling, Phase I
Updated: 12/31/1969
mi
from
Orlando, FL
Click here to add this to my saved trials
Hepatic Impairment Clinical Trial
A Study to Evaluate the Effect of Hepatic Impairment on the Pharmacokinetics of Glasdegib
Status: Enrolling, Phase I
Updated: 12/31/1969
mi
from
Orlando, FL
Click here to add this to my saved trials
Gout Clinical Trial
Safety and Pharmacodynamics of SEL-212 (Pegsiticase + SEL-110) in Subjects With Elevated Blood Uric Acid Levels
Status: Enrolling, Phase I
Updated: 1/6/2016
mi
from
Orlando, FL
Click here to add this to my saved trials
Hepatic Impairment Clinical Trial
Tepotinib Hepatic Impairment Trial
Status: Enrolling, Phase I
Updated: 12/31/1969
mi
from
Orlando, FL
Click here to add this to my saved trials
Endocrinology, Nephrology / Urology Clinical Trial
A Study to Asses Pharmacokinetics, Safety, and Tolerability of DM199 in Patients With Diabetes Mellitus and Chronic Kidney Disease
Status: Enrolling, Phase I
Updated: 12/31/1969
mi
from
Orlando, FL
Click here to add this to my saved trials